Monday, June 15, 2026

SJN314: The Promising New Immunotherapy for Chronic Inflammatory Diseases in Asia

Samjin Pharmaceutical submits phase 1 trial plan for SJN314, targeting immune diseases, aiming for global partnerships in early clinical phases.

New Study Suggests Ginkgo Biloba Extract May Slow Beta-Amyloid Aggregation in Mild Cognitive Impairment

Ginkgo biloba extract shows promise in inhibiting beta-amyloid aggregation, potentially preventing Alzheimer's in MCI patients.

How This New Blood Test Using Nanotechnology Could Change Brain Disease Monitoring Forever

South Korean researchers developed a blood test to track brain disease progression, potentially replacing imaging scans for monitoring.

Tag: Geffen Records

North KoreaKoreaKimMilitaryAISouth KoreamarketrelationsInternational

No posts to display

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.